News & Perspective

Dec 16, 2002

Dec 16, 2002

Half of second target group for smallpox shots may refuse them, officials estimate

(CIDRAP News) – Federal health officials project that about half of the estimated 10 million health and emergency response workers targeted for the second round of smallpox vaccinations will refuse the shots.

Dec 12, 2002

Dec 12, 2002

Some health workers, troops likely to get smallpox shots soon; public in 2004

(CIDRAP News) – President Bush tomorrow will announce a plan to begin vaccinating military personnel and front-line healthcare workers against smallpox early next year and to offer the vaccine to the public in 2004, according to reports from major news organizations today.

Dec 05, 2002

Dec 05, 2002

With smallpox vaccination campaign likely, CDC seeks to expand VIG supply

(CIDRAP News) – As the likelihood of a large-scale smallpox vaccination program grows, the Centers for Disease Control and Prevention (CDC) is seeking to expand the government's limited supply of vaccinia immune globulin (VIG), the mainstay of treatment for severe reactions to the vaccine.

Nov 22, 2002

Nov 22, 2002

Homeland Security law leaves HHS in control of bioterrorism preparedness

(CIDRAP News) – In passing a bill to create a Department of Homeland Security (DHS) this week, Congress left the Department of Health and Human Services (HHS) in charge of most bioterrorism preparedness and civilian biodefense research programs—to the relief of medical research and public health groups.

Nov 18, 2002

Nov 18, 2002

Decision on smallpox vaccinations expected soon, Osterholm says

(CIDRAP News) – Now that the federal government has some licensed smallpox vaccine in its stockpile, a presidential announcement on vaccination recommendations may be coming very soon, bioterrorism expert Michael T. Osterholm, PhD, MPH, predicted last week.

"I believe that in the next days you'll be hearing from the president about this vaccine," Osterholm told healthcare workers at a meeting in Minneapolis.

Nov 08, 2002

Nov 08, 2002

GAO: Military anthrax shots caused many reactions, prompted some pilots to quit

(CIDRAP News) – The Pentagon's mandatory anthrax shots caused adverse reactions in most recipients and helped prompt many Air Force Reserve and Air National Guard members to transfer to other units or leave the military between 1998 and 2000, according to a survey by Congress's General Accounting Office (GAO).

Nov 05, 2002

Nov 05, 2002

FDA licenses repackaged smallpox vaccine from federal stockpile

(CIDRAP News) – The Food and Drug Administration (FDA) has updated the licensing for the government's decades-old stockpile of Dryvax smallpox vaccine by approving a new vaccine kit that includes a new diluent and bifurcated needles, according to federal officials.

Sep 11, 2002

Sep 11, 2002

IOM says military vaccine program needs revamping, more money

(CIDRAP News) – The Department of Defense's (DoD's) vaccine acquisition program is poorly organized and underfunded, making it difficult for the department to obtain important vaccines and maintain the supply of existing ones, according to a new report from the Institute of Medicine (IOM).

Aug 27, 2002

Aug 27, 2002

Bacteriophage enzyme selectively detects and kills anthrax, researchers say

(CIDRAP News) – Researchers at Rockefeller University report that they have isolated an enzyme from a bacteriophage that shows promise as a tool to quickly detect and kill Bacillus anthracis, the anthrax bacterium.

Jul 01, 2002

Jul 01, 2002

Pentagon will turn over part of anthrax vaccine supply for civilian use

July 1, 2002 (CIDRAP News) – About half of the nation's supply of anthrax vaccine—previously dedicated almost entirely to military use—will henceforward be set aside for civilian use in the event of another anthrax attack, federal defense and health officials announced Jun 28.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»